Next Science Ltd
ASX:NXS
Next Science Ltd
ASX:NXS
Price:
0.315 AUD
-5.97%
Market Closed
Updated:
May 18, 2024
Balance Sheet
Balance Sheet Decomposition
Next Science Ltd
Next Science Ltd
| Current Assets | 14m |
| Cash & Short-Term Investments | 9.3m |
| Receivables | 3.6m |
| Other Current Assets | 1.1m |
| Non-Current Assets | 3.9m |
| PP&E | 1.5m |
| Intangibles | 2.4m |
| Other Non-Current Assets | 36.7k |
| Current Liabilities | 3.8m |
| Accounts Payable | 3.2m |
| Accrued Liabilities | 79.7k |
| Other Current Liabilities | 549.7k |
| Non-Current Liabilities | 1.2m |
| Long-Term Debt | 687.2k |
| Other Non-Current Liabilities | 555.6k |
Balance Sheet
Next Science Ltd
Next Science Ltd
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
1
|
7
|
17
|
8
|
7
|
5
|
9
|
|
| Cash |
1
|
1
|
7
|
17
|
8
|
7
|
5
|
9
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
2
|
3
|
1
|
2
|
4
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
3
|
1
|
2
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
1
|
2
|
9
|
19
|
20
|
10
|
8
|
14
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
|
| Intangible Assets |
0
|
1
|
1
|
2
|
2
|
3
|
2
|
2
|
|
| Note Receivable |
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
7
+369%
|
11
+42%
|
23
+114%
|
24
+4%
|
14
-42%
|
12
-9%
|
18
+44%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
2
|
1
|
1
|
2
|
|
| Total Current Liabilities |
0
|
1
|
9
|
2
|
3
|
2
|
3
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
2
|
1
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
0
N/A
|
1
+230%
|
10
+1 143%
|
3
-67%
|
5
+42%
|
3
-38%
|
4
+50%
|
5
+15%
|
|
| Equity | |||||||||
| Common Stock |
11
|
18
|
57
|
91
|
101
|
103
|
114
|
134
|
|
| Retained Earnings |
10
|
11
|
56
|
70
|
82
|
91
|
104
|
120
|
|
| Other Equity |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
|
| Total Equity |
1
N/A
|
7
+395%
|
0
-94%
|
19
+4 696%
|
19
-2%
|
11
-43%
|
8
-25%
|
13
+60%
|
|
| Total Liabilities & Equity |
2
N/A
|
7
+369%
|
11
+42%
|
23
+114%
|
24
+4%
|
14
-42%
|
12
-9%
|
18
+44%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
179
|
179
|
179
|
180
|
194
|
198
|
215
|
292
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
